Eisai Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Eisai and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 11076 Eisai employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Eisai has purchased the following applications: Medidata Clinical Data Studio for Clinical Trial Management in 2024, Amazon EC2 for Application Hosting and Computing Services in 2015 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Eisai is running and its propensity to invest more and deepen its relationship with Dassault Systemes , Amazon Web Services (AWS) or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Eisai revenues, which have grown to $4.92 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Eisai intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Dassault Systemes | Legacy | Medidata Clinical Data Studio | Clinical Trial Management | ERP Services and Operations | n/a | 2024 | 2024 |
In 2024, Eisai Inc. deployed Medidata Clinical Data Studio as part of its Clinical Trial Management capability. Eisai will leverage Medidata Clinical Data Studio to centralize clinical and patient data, enable execution of scalable and complex clinical trials, and enhance patient experience while maintaining quality and integrity across data sources.
Medidata Clinical Data Studio is powered by the Medidata Platform, providing a unified data management layer that centrally manages disparate data sources and analytics workflows. Implemented functional capabilities include AI driven data review and visualization, concurrent review of patient records, automated import and validation processes, and configuration of data transfer agreements to enforce validation rules and data quality standards.
The deployment integrates Medidata sources including Medidata Rave EDC and non Medidata sources such as laboratory feeds and alternate electronic data capture systems, streamlining imports and standardizing validation across systems. Operational coverage is focused on Eisai Inc. clinical operations and study teams responsible for trial execution, data monitoring, and patient data review.
Governance and workflow adjustments center on configurable data transfer agreements and automated validation to break down data silos and enable tighter data stewardship without adding headcount. The AI driven review capability offers up to 80 percent faster data review while providing a comprehensive, actionable view of patient data, supporting faster identification of data issues and improved collaboration across study teams.
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Amazon Web Services (AWS) | Legacy | Amazon EC2 | Application Hosting and Computing Services | IaaS | n/a | 2015 | 2015 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2019 | 2019 |
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||